SCHEMBL6087450

SCHEMBL6087450

CCc1c(Oc2cc(C)cc(C)c2)n(Cc2ccc3c(c2)C(=O)c2ccccc2C3=O)c(=O)[nH]c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
NPSR1 Q6W5P4 1/20 0.36
NAT1 P18440 1/20 0.35
HSP90AB1 P08238 2/20 0.35
DRD1 P21728 2/20 0.35
ELANE P08246 1/20 0.34
HPGD P15428 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HTT P42858 2/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086864 0.87 HPGD (0.44) MAPTALDH1A1MAPK1KMT2AMEN1
SCHEMBL6087014 0.87 DAO (0.46) MAPTALDH1A1MAPK1KMT2AMEN1
SCHEMBL6086860 0.86 ALDH1A1 (0.37) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL6087044 0.84 SMN1; SMN2 (0.37) MAPTALDH1A1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL6086483 0.82 MTNR1A (0.50) ALDH1A1KMT2AMEN1TSHR
SCHEMBL6086212 0.80 MAPT (0.42) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL6086881 0.80 SMN1; SMN2 (0.42) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL6087695 0.80 GRIN1 (0.44) KMT2A
SCHEMBL6085671 0.80 GRIN1 (0.44) ALDH1A1MAPK1HPGD
SCHEMBL6086259 0.79 GRIN1 (0.37) ALDH1A1SMN1; SMN2KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6987114-B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof SAMJIN PHARMACEUTICAL CO., LTD (KR) 2006-01-17 US disclosed